A $414M, trust-floor-protected call option on Michael Klein’s ability to land a top-tier SPAC 4.0 merger—high asymmetry now, true risk only after the de-SPAC.
Overview
Churchill Capital Corp XII (CXIIU) is the twelfth SPAC in Michael Klein’s Churchill franchise, incorporated in the Cayman Islands in 2025 and designed to raise public capital to acquire a private operating company. On April 29, 2026 it closed an upsized IPO raising $414M in gross proceeds—well above the initial $300M plan—signaling strong institutional demand for the Churchill platform amid a 2026 SPAC market recovery. As a pre-combination SPAC, CXIIU has no operating revenue; its economics are driven by interest on trust assets and by the market’s confidence in sponsor selection. Each $10 unit bundles one Class A share (a claim on the trust, creating a ~$10 floor) and 1/10 of a redeemable warrant (lower dilution than legacy SPACs). Churchill targets high-barrier, recurring-revenue, cash-flow-capable businesses across sectors, with prior franchise activity spanning EVs (Lucid), healthcare tech (MultiPlan), and frontier tech (quantum/autonomy). The investment proposition is asymmetric: limited downside via redemption plus upside if Klein and the operating-partner network secure a high-quality, market-leading target and strong PIPE support.